Adcendo is adding $135 million to its arsenal, money that will go toward launching several antibody-drug conjugate (ADC) ...

Venture capital firms incubate, grow and finance dozens of drug companies each year. Follow the money they channel into the ...

Enveda, a company using artificial intelligence to boost nature-based drug discovery, is envisioning clinical success with a ...

AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it's never quite as straightforward to ...

The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

The retail giant's CEO, Doug McMillon, started working for the company in high school, eventually rising to CEO in 2014. Here ...

Short interest in SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) decreased during the last reporting period, falling from 56.89M to 55.94M. This put -% of the company's publicly available ...

BEIJING, CHINA - Media OutReach Newswire - 22 November 2024 - The 2024 Beijing Changping Forum on Life Science, themed ...

Fidelity Select Biotechnology Portfolio earns an Above ... income division and a strong team supporting its target-date series, and it's home to some of the industry's most talented equity managers.